Company

ImmuPharma PLC

Biotechnology Research London, City of, United Kingdom 6 employees

Employees: 6
Contacts: 1
Emails: 1

immupharma.com LinkedIn Crunchbase

ImmuPharma PLC Overview

Headquarters: London, City of, United Kingdom
Website: immupharma.com
Industry: Biotechnology Research
Employees: 6
Founded: 2001
Funding: 12.1M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Autoimmune diseases Peptides Oncology

About ImmuPharma PLC

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140,is a first-in class “immune tolerance restorer” for the treatment of SLE (Systemic Lupus Erythematosus) and CIDP (Chronic Idiopathic Demyelinating Polyneuropathy) and preclinical models suggest therapeutic activity for many other autoimmune diseases that share the same mechanism of action.

ImmuPharma PLC Contact Details

People in AeroLeads: 2
With contact data: 1
Email contacts: 1; 50.0% coverage

ImmuPharma PLC Org Chart

Sample employees and titles

Name	Title	Location	Contact
Charles Defour	Bsc Chemistry Undergrad at Swansea University	Swansea, Wales, United Kingdom	View
Lisa Baderoon	Founder of Just B Communications Ltd	Hove, England, United Kingdom	Email